.png)
.png)
Clinical Assistant Professor, Director of Infectious Diseases Improvement and Clinical Research Innovation
University of Pittsburgh School of Medicine
Disclosure(s): AbbVie: Advisor/Consultant; Cidara: Advisor/Consultant; Entasis: Advisor/Consultant; Ferring: Advisor/Consultant; Merck: Advisor/Consultant; Shionogi: Advisor/Consultant; Summit: Advisor/Consultant
Erin McCreary, PharmD, BCPS, BCIDP is a Clinical Assistant Professor within the University of Pittsburgh Department of Medicine, Division of Infectious Diseases (ID) and the Director of Infectious Diseases Improvement and Clinical Research Innovation for UPMC. She received her PharmD from the Auburn University Harrison School of Pharmacy and completed her PGY1 Pharmacy and PGY2 Infectious Diseases residencies at the University of Wisconsin Health.
Dr. McCreary co-chairs the UPMC COVID-19 Therapeutics Committee and served as a co-investigator for the REMAP-CAP trial, a global, adaptive, clinical trial evaluating multiple therapies for COVID-19. She has also led system-wide implementation of multiple infectious diseases and antimicrobial stewardship initiatives. She has published numerous peer-reviewed manuscripts in the areas of antimicrobial stewardship and infectious diseases. She also serves on the Society of Infectious Diseases Pharmacists Executive Board and a host of Breakpoints—The SIDP Podcast.
Her practice and research interests include infectious diseases and antimicrobial stewardship in immunocompromised hosts, gram-negative resistance, and antimicrobial pharmacokinetic/pharmacodynamic optimization. She is also passionate about professional leadership, mentorship, and preceptorship.
You can find her on Twitter @erinmccreary